is tirzepatide used for sleep apnea and Obesity: Risks, Policy, and (Zepbound®) FDA Approves Zepbound for Sleep

WW recommends signing up for the month-to-month plan if youre unsure about trying weight loss medication at first

This is where GLP-1 medications change the narrative

Large-scale trials including SUSTAIN-6 have demonstrated cardiovascular benefits and reduced major adverse cardiovascular events in high-risk patients

Adaptive Immunity

The Lancet 397:971984 Borlaug BA, Kitzman DW, Davies MJ et al (2023) Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Given that GLP-1 RAs result in weight loss and the pronounced effects of weight loss on haemodynamic disturbance and cardiac reverse remodelling in obese HF patients, the question is, to what extent is the effect of the drugs related to a direct effect on the cardiovascular system in HF